ID: ALA3099483

Max Phase: Preclinical

Molecular Formula: C17H21NO3

Molecular Weight: 287.36

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1ccc2c3c1O[C@@H]1C[C@H](O)C=C[C@]31CCN([11CH3])C2

Standard InChI:  InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m1/s1/i1-1

Standard InChI Key:  ASUTZQLVASHGKV-CTPQCZGMSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 287.36

Molecular Weight (Monoisotopic): 287.1521

AlogP: 1.85

#Rotatable Bonds: 1

Polar Surface Area: 41.93

Molecular Species: BASE

HBA: 4

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 8.58

CX LogP: 1.16

CX LogD: -0.04

Aromatic Rings: 1

Heavy Atoms: 21

QED Weighted: 0.80

Np Likeness Score: 2.11

References

1. Kimura H, Kawai T, Hamashima Y, Kawashima H, Miura K, Nakaya Y, Hirasawa M, Arimitsu K, Kajimoto T, Ohmomo Y, Ono M, Node M, Saji H..  (2014)  Synthesis and evaluation of (-)- and (+)-[¹¹C]galanthamine as PET tracers for cerebral acetylcholinesterase imaging.,  22  (1): [PMID:24315193] [10.1016/j.bmc.2013.11.026]

Source

Source(1):

• Scientific Literature